Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?

Abstract Background The ISPOR Special Task Force (STF) on US Value Assessment Frameworks was agnostic about exactly how to implement the quality-adjusted life year (QALY) as a key element in an overall cost-effectiveness evaluation. But the STF recommended using the cost-per-QALY gained as a startin...

Full description

Bibliographic Details
Main Authors: Bernarda Zamora, Louis P. Garrison, Aig Unuigbe, Adrian Towse
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Online Access:https://doi.org/10.1186/s12962-021-00266-8